# Squadron Capital Management LLC: Form 13F holdings

An institutional investment manager in OAK BROOK, IL. SEC CIK 2050709.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $322.2m
- Positions: 43 (43 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2050709/000205070926000027/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [RELMADA THERAPEUTICS INC (RLMD)](/companies/rlmd.md) | COM | $50.9m | 15.8% | 7,350,000 |  | Reduced −1,124,571 |
| [C4 THERAPEUTICS INC (CCCC)](/companies/cccc.md) | COM STK | $33.6m | 10.4% | 7,200,000 |  | Added +4,950,000 |
| [COGENT BIOSCIENCES INC (COGT)](/companies/cogt.md) | COM | $33.5m | 10.4% | 865,000 |  | Added +77,508 |
| [KODIAK SCIENCES INC (KOD)](/companies/kod.md) | COM | $19.5m | 6.0% | 500,000 |  | Added +120,000 |
| [RELAY THERAPEUTICS INC (RLAY)](/companies/rlay.md) | COM | $18.1m | 5.6% | 970,000 |  | Added +297,500 |
| [ZENTALIS PHARMACEUTICALS INC (ZNTL)](/companies/zntl.md) | COM | $17.9m | 5.6% | 3,700,000 |  | Added +69,000 |
| [EDGEWISE THERAPEUTICS INC (EWTX)](/companies/ewtx.md) | COM | $11.8m | 3.7% | 290,000 |  | Reduced −60,000 |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COM | $10.0m | 3.1% | 335,000 |  | Added +77,500 |
| [INVENTIVA SA (IVA)](/companies/iva.md) | ADS | $9.2m | 2.9% | 2,435,000 |  | Added +1,900,000 |
| [ADLAI NORTYE LTD (ANL)](/companies/anl.md) | SPONSORED ADS | $8.8m | 2.7% | 764,876 |  | Reduced −500,355 |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $8.1m | 2.5% | 160,000 |  | New +160,000 |
| [ARRIVENT BIOPHARMA INC (AVBP)](/companies/avbp.md) | COM | $6.4m | 2.0% | 183,000 | Call | Added +73,000 |
| [PALISADE BIO INC (PALI)](/companies/pali.md) | COM | $6.3m | 1.9% | 3,000,000 |  | Unchanged |
| [BIOAGE LABS INC (BIOA)](/companies/bioa.md) | COM | $6.1m | 1.9% | 250,000 | Call | New +250,000 |
| [INHIBIKASE THERAPEUTICS INC (IKT)](/companies/ikt.md) | COM NEW | $6.1m | 1.9% | 3,000,000 |  | Reduced −500,000 |
| [ADAGENE INC (ADAG)](/companies/adag.md) | ADS | $5.3m | 1.6% | 1,250,000 |  | New +1,250,000 |
| FORTE BIOSCIENCES INC | COM NEW | $4.8m | 1.5% | 225,000 |  | New +225,000 |
| [REZOLUTE INC (RZLT)](/companies/rzlt.md) | COM NEW | $4.7m | 1.5% | 900,000 | Call | New +900,000 |
| INFLARX NV | COM | $4.5m | 1.4% | 2,000,000 |  | New +2,000,000 |
| [ASSEMBLY BIOSCIENCES INC (ASMB)](/companies/asmb.md) | COM NEW | $4.4m | 1.4% | 160,000 |  | New +160,000 |
| [COMPASS PATHWAYS PLC (CMPS)](/companies/cmps.md) | SPONSORED ADS | $4.3m | 1.3% | 305,000 | Call | New +305,000 |
| [PROMIS NEUROSCIENCES INC (PMN)](/companies/pmn.md) | COM SHS | $4.3m | 1.3% | 324,977 |  | Unchanged |
| [CONTINEUM THERAPEUTICS INC (CTNM)](/companies/ctnm.md) | CL A | $4.3m | 1.3% | 260,000 |  | New +260,000 |
| [COMPASS PATHWAYS PLC (CMPS)](/companies/cmps.md) | SPONSORED ADS | $4.2m | 1.3% | 300,000 |  | New +300,000 |
| [DEFINIUM THERAPEUTICS INC (DFTX)](/companies/dftx.md) | COM SHS | $4.0m | 1.2% | 85,000 |  | New +85,000 |
| SOL-GEL TECHNOLOGIES LTD | SHS NEW | $3.9m | 1.2% | 52,000 |  | Added +21,000 |
| [BIOAGE LABS INC (BIOA)](/companies/bioa.md) | COM | $3.8m | 1.2% | 155,000 |  | New +155,000 |
| [SCYNEXIS INC (SCYX)](/companies/scyx.md) | COM | $3.1m | 1.0% | 756,884 |  | New +756,884 |
| PROQR THRAPEUTICS N V | SHS EURO | $2.8m | 0.9% | 1,511,496 |  | New +1,511,496 |
| [DISC MEDICINE INC (IRON)](/companies/iron.md) | COM | $2.2m | 0.7% | 30,000 | Call | New +30,000 |
| [REZOLUTE INC (RZLT)](/companies/rzlt.md) | COM NEW | $2.1m | 0.7% | 403,410 |  | New +403,410 |
| [LIPOCINE INC NEW (LPCN)](/companies/lpcn.md) | COM NEW | $2.1m | 0.6% | 810,000 |  | Added +360,000 |
| [ZENTALIS PHARMACEUTICALS INC (ZNTL)](/companies/zntl.md) | COM | $2.1m | 0.6% | 426,000 | Call | Added +26,000 |
| [C4 THERAPEUTICS INC (CCCC)](/companies/cccc.md) | COM STK | $1.9m | 0.6% | 400,000 | Call | New +400,000 |
| [ULTRAGENYX PHARMACEUTICAL IN (RARE)](/companies/rare.md) | COM | $1.8m | 0.6% | 55,000 | Call | New +55,000 |
| [CUE BIOPHARMA INC (CUE)](/companies/cue.md) | COM | $1.6m | 0.5% | 50,000 |  | New +50,000 |
| CALCIMEDICA INC | COM NEW | $1.3m | 0.4% | 1,244,864 |  | New +1,244,864 |
| [QUINCE THERAPEUTICS INC (IRLA)](/companies/irla.md) | COM | $734.4k | 0.2% | 40,375 |  | New +40,375 |
| [NUVECTIS PHARMA INC (NVCT)](/companies/nvct.md) | COM | $711.7k | 0.2% | 38,700 | Call | New +38,700 |
| [PASITHEA THERAPEUTICS CORP (KTTA)](/companies/ktta.md) | COM NEW | $515.4k | 0.2% | 1,000,000 |  | Reduced −1,100,000 |
| [INMED PHARMACEUTICALS INC (INM)](/companies/inm.md) | COM NEW | $503.8k | 0.2% | 325,000 |  | New +325,000 |
| [NEUMORA THERAPEUTICS INC. (NMRA)](/companies/nmra.md) | COM | $170.0k | <0.1% | 100,000 |  | New +100,000 |
| [NEXTCURE INC (NXTC)](/companies/nxtc.md) | COM NEW | $103.1k | <0.1% | 64,464 |  | Reduced −200,536 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −130,000 |
| [ALX ONCOLOGY HLDGS INC (ALXO)](/companies/alxo.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,460,000 |
| [CONTEXT THERAPEUTICS INC (CNTX)](/companies/cntx.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,100,000 |
| [EUPRAXIA PHARMACEUTICALS INC (EPRX)](/companies/eprx.md) | COM | $0 | 0.0% | 0 |  | Sold out −680,000 |
| GH RESEARCH PLC | ORDINARY SHARES | $0 | 0.0% | 0 |  | Sold out −325,000 |
| [IDEAYA BIOSCIENCES INC (IDYA)](/companies/idya.md) | COM | $0 | 0.0% | 0 | Put | Sold out −120,000 |
| [IDEAYA BIOSCIENCES INC (IDYA)](/companies/idya.md) | COM | $0 | 0.0% | 0 | Call | Sold out −104,300 |
| KALVISTA PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −985,100 |
| KALVISTA PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 | Call | Sold out −315,000 |
| [KARYOPHARM THERAPEUTICS INC (KPTI)](/companies/kpti.md) | COM NEW | $0 | 0.0% | 0 | Put | Sold out −750,000 |
| [NEKTAR THERAPEUTICS (NKTR)](/companies/nktr.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −125,000 |
| [NEUPHORIA THERAPEUTICS INC (NEUP)](/companies/neup.md) | COM | $0 | 0.0% | 0 |  | Sold out −76,728 |
| [RELAY THERAPEUTICS INC (RLAY)](/companies/rlay.md) | COM | $0 | 0.0% | 0 | Call | Sold out −150,000 |
| SCYNEXIS INC | COM NEW | $0 | 0.0% | 0 |  | Sold out −7,608,695 |
| [SPRUCE BIOSCIENCES INC (SPRB)](/companies/sprb.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −12,200 |
| [THERAPEUTICSMD INC (TXMD)](/companies/txmd.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −420,421 |
| [TRAWS PHARMA INC (TRAW)](/companies/traw.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −511,714 |
| [WEREWOLF THERAPEUTICS INC (HOWL)](/companies/howl.md) | COM | $0 | 0.0% | 0 |  | Sold out −563,535 |

Source: SEC EDGAR, Form 13F-HR, accession 0002050709-26-000027. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.